| |
Patient follow-up |
| Cytologic features |
No malignancy (n=32) |
Epithelial malignancy (n=1) |
Hematolymphoid malignancy (n=3) |
P value |
| Location of effusion |
|
|
|
0.06^ |
| Contralateral |
1 (3%) |
1 (100%) |
0 (0%) |
| Ipsilateral |
31 (97%) |
0 (0%) |
3 (100%) |
| Prominent nucleoli |
15 (47%) |
1 (100%) |
0 (0%) |
0.29* |
| Cell clusters |
11 (34%) |
1 (100%) |
1 (33%) |
0.17* |
| Cell clusters with community borders |
1 (3%) |
1 (100%) |
0 (0%) |
0.01* |
| Vacuolated cells |
15 (47%) |
1 (100%) |
0 (0%) |
0.29* |
| Recurrent effusion |
8 (25%) |
1 (100%) |
1 (33%) |
0.29 |
| * These p values were calculated excluding hematolymphoid malignancies as these are features of epithelial malignancies
^ This p value was calculated for patients with a unilateral lung transplant (n=9) and only for epithelial malignancies (p=0.06), as all hematopoietic malignancies developed in patients with bilateral lung transplants. |
